Tetra Bio-Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 39

Employees

  • Stock Symbol
  • TBPMQ

Stock Symbol

  • Investments
  • 8

Tetra Bio-Pharma General Information

Description

Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

Contact Information

Formerly Known As
GrowPros Cannabis Ventures
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 2316 Saint Joseph Boulevard
  • Orleans, Ontario K1C 1E8
  • Canada
+1 (343)
Primary Industry
Specialty Retail
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 2316 Saint Joseph Boulevard
  • Orleans, Ontario K1C 1E8
  • Canada
+1 (343)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetra Bio-Pharma Stock Performance

As of 19-Jan-2024, Tetra Bio-Pharma’s current market cap is $84.7K.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$84.7K 284K -$0.06

Tetra Bio-Pharma Financials Summary

As of 31-Aug-2022, Tetra Bio-Pharma has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Aug-2022 FY 2021 30-Nov-2021 FY 2020 30-Nov-2020 FY 2019 30-Nov-2019
EV 19,727 64,932 31,703 55,124
Revenue 0 0 0 0
EBITDA (30,213) (40,078) (15,775) (9,885)
Net Income (30,653) (41,594) (19,686) (11,494)
Total Assets 2,306 5,926 22,595 21,497
Total Debt 1,268 2,442 1,540 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tetra Bio-Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.

Request a free trial

Tetra Bio-Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical program
Specialty Retail
Orleans, Canada
39 As of 2025

Basel, Switzerland
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tetra Bio-Pharma Competitors (6)

One of Tetra Bio-Pharma’s 6 competitors is Roche, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roche Corporation Basel, Switzerland
Revive Therapeutics Corporation Toronto, Canada
Cipla Corporation Mumbai, India
Repare Therapeutics Formerly VC-backed Saint-Laurent, Canada
Quantum BioPharma Corporation Toronto, Canada
To view Tetra Bio-Pharma’s complete competitors history, request access »

Tetra Bio-Pharma Patents

Tetra Bio-Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022133612-A1 Parenteral cannabinoid formulations and uses thereof Inactive 24-Dec-2020
US-12129227-B2 Methods, processes, and compositions for improved preparation of hu308 and hu433 Active 24-Sep-2020
US-20230271908-A1 Methods, processes, and compositions for improved preparation of hu308 and hu433 Active 24-Sep-2020
WO-2022061461-A1 Methods, processes, and compositions for improved preparation of hu308 and hu433 Inactive 24-Sep-2020
AU-2019409889-A1 Cannabis compositions and methods Inactive 18-Dec-2018 A61K31/658
To view Tetra Bio-Pharma’s complete patent history, request access »

Tetra Bio-Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tetra Bio-Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.

Request a free trial

Tetra Bio-Pharma Investments & Acquisitions (8)

Tetra Bio-Pharma’s most recent deal was a Corporate with TALLC (Drug Discovery). The deal was made on 03-Jun-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TALLC (Drug Discovery) 03-Jun-2020 Corporate Drug Discovery
CB2 Therapeutics 21-Aug-2019 Joint Venture Drug Discovery
Panag Pharma 01-May-2019 Merger/Acquisition Drug Discovery
Joint Venture (Tetra Bio-Pharma and Altus Formulation) 29-Apr-2019 Joint Venture Drug Delivery
Phytopain Pharma 19-Mar-2018 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Tetra Bio-Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Precious Metals

Industry

Rank

Percentile

Gold

Subindustry

Rank

Percentile

To view Tetra Bio-Pharma’s complete esg history, request access »

Tetra Bio-Pharma Exits (2)

Tetra Bio-Pharma’s most recent exit was on 22-Jun-2016 from Holizen. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Holizen 22-Jun-2016 Completed
Export Hydro 06-Nov-2015 Merger/Acquisition Completed
To view Tetra Bio-Pharma’s complete exits history, request access »

Tetra Bio-Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Targeted Pharmaceuticals Marlborough, MA 2018

Tetra Bio-Pharma FAQs

  • When was Tetra Bio-Pharma founded?

    Tetra Bio-Pharma was founded in 2007.

  • Where is Tetra Bio-Pharma headquartered?

    Tetra Bio-Pharma is headquartered in Orleans, Canada.

  • What is the size of Tetra Bio-Pharma?

    Tetra Bio-Pharma has 39 total employees.

  • What industry is Tetra Bio-Pharma in?

    Tetra Bio-Pharma’s primary industry is Specialty Retail.

  • Is Tetra Bio-Pharma a private or public company?

    Tetra Bio-Pharma is a Public company.

  • What is Tetra Bio-Pharma’s stock symbol?

    The ticker symbol for Tetra Bio-Pharma is TBPMQ.

  • What is the current market cap of Tetra Bio-Pharma?

    The current market capitalization of Tetra Bio-Pharma is $84.7K.

  • Who are Tetra Bio-Pharma’s competitors?

    Roche, Revive Therapeutics, Cipla, Repare Therapeutics, and Quantum BioPharma are some of the 6 competitors of Tetra Bio-Pharma.

  • What is Tetra Bio-Pharma’s annual earnings per share (EPS)?

    Tetra Bio-Pharma’s EPS for 12 months was -$0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process